Growth hormone therapy for patients with Turner's syndrome.
The linear growth of 8 patients with Turner's syndrome during human growth hormone (GH) administration was documented. Mean growth velocity was significantly greater during GH treatment (4.9 +/- 0.8 cm/year) than before treatment (3.3 +/- 0.8 cm/year, p less than 0.001). Growth velocity was related to dosage but not correlated with chronologic age, skeletal age or weight.
D000293:Adolescent; D002648:Child; D005260:Female; D005951:Glucose Tolerance Test; D006128:Growth / Q000187:drug effects; D013006:Growth Hormone / Q000627:therapeutic use*; D006801:Humans; D013002:Somatomedins / Q000097:blood; D014424:Turner Syndrome / Q000097:blood / Q000188:drug therapy*
D013002:Somatomedins; D013006:Growth Hormone